Search research articles
Contact Us
Filters
Showing results (411-420 of 431) with videos related to
Page
of 44
Sort By:
Toxicology Letters
|
August 30, 2019
Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker
C L Ursini, E Omodeo Salè, A M Fresegna, et al.
Oncology Reports
|
April 30, 2010
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study
M F Morelli, A Santomaggio, E Ricevuto, et al.
Journal of Hematology & Oncology
|
October 31, 2019
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
E Krasniqi, G Barchiesi, L Pizzuti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2020
Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial
F Petrelli, E Rulli, R Labianca, et al.
Diabetologia
|
December 25, 2010
Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion
G da Silva Xavier, H Farhan, H Kim, et al.
Transplantation Proceedings
|
April 28, 2004
To give or to receive? Opinions of teenagers on kidney donation
G B Piccoli, G Soragna, S Putaggio, et al.
Human Mutation
|
October 17, 2007
Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online
O Porzio, O Massa, V Cunsolo, et al.
Progress in Neuro-Psychopharmacology
|
January 1, 1981
A multicenter controlled trial in phobic-obsessive psychoneurosis. The effect of chlorimipramine and of its combinations with haloperidol and diazepam
G B Cassano, P Castrogiovanni, M Mauri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
S Lonardi, A Sobrero, G Rosati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
S Lonardi, A Sobrero, G Rosati, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 431) with videos related to
Sort By:
Page
of 44
Toxicology Letters
|
August 30, 2019
Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker
C L Ursini, E Omodeo Salè, A M Fresegna, et al.
Oncology Reports
|
April 30, 2010
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study
M F Morelli, A Santomaggio, E Ricevuto, et al.
Journal of Hematology & Oncology
|
October 31, 2019
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
E Krasniqi, G Barchiesi, L Pizzuti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2020
Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial
F Petrelli, E Rulli, R Labianca, et al.
Diabetologia
|
December 25, 2010
Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion
G da Silva Xavier, H Farhan, H Kim, et al.
Transplantation Proceedings
|
April 28, 2004
To give or to receive? Opinions of teenagers on kidney donation
G B Piccoli, G Soragna, S Putaggio, et al.
Human Mutation
|
October 17, 2007
Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online
O Porzio, O Massa, V Cunsolo, et al.
Progress in Neuro-Psychopharmacology
|
January 1, 1981
A multicenter controlled trial in phobic-obsessive psychoneurosis. The effect of chlorimipramine and of its combinations with haloperidol and diazepam
G B Cassano, P Castrogiovanni, M Mauri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
S Lonardi, A Sobrero, G Rosati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
S Lonardi, A Sobrero, G Rosati, et al.
Page
of 44